Werewolf Therapeutics (NASDAQ:HOWL – Get Rating) is one of 937 public companies in the “Pharmaceutical preparations” industry, but how does it contrast to its peers? We will compare Werewolf Therapeutics to related companies based on the strength of its risk, earnings, institutional ownership, dividends, valuation, analyst recommendations and profitability. Earnings and Valuation This table compares […]
Werewolf Therapeutics (NASDAQ:HOWL – Get Rating) released its quarterly earnings results on Thursday. The company reported ($0.66) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.53) by ($0.13), MarketWatch Earnings reports. Werewolf Therapeutics stock traded up $0.19 during midday trading on Friday, reaching $3.90. The company’s stock had a trading volume of […]